Clinical Trial Update: A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on a biomarker-targeted approach to optimize treatment in chronic kidney disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: Peter Rossing | Conditions: Chronic Kidney Disease(CKD) | Phase 4 | Status: RECRUITING